These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1518862)

  • 1. Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo.
    Raychaudhuri S; Tonks M; Carbone F; Ryskamp T; Morrow WJ; Hanna N
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8308-12. PubMed ID: 1518862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans.
    Doe B; Steimer KS; Walker CM
    Eur J Immunol; 1994 Oct; 24(10):2369-76. PubMed ID: 7523139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants.
    Sheikh NA; Rajananthanan P; Attard GS; Morrow WJ
    Vaccine; 1999 Aug; 17(23-24):2974-82. PubMed ID: 10462232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming of anti-human immunodeficiency virus (HIV) CD8+ cytotoxic T cells in vivo by carrier-free HIV synthetic peptides.
    Hart MK; Weinhold KJ; Scearce RM; Washburn EM; Clark CA; Palker TJ; Haynes BF
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9448-52. PubMed ID: 1946358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses.
    Speidel K; Osen W; Faath S; Hilgert I; Obst R; Braspenning J; Momburg F; Hämmerling GJ; Rammensee HG
    Eur J Immunol; 1997 Sep; 27(9):2391-9. PubMed ID: 9341785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.
    Wagner R; Böltz T; Deml L; Modrow S; Wolf H
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1261-9. PubMed ID: 7687647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.
    Schirmbeck R; Melber K; Kuhröber A; Janowicz ZA; Reimann J
    J Immunol; 1994 Feb; 152(3):1110-9. PubMed ID: 8301120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
    De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells.
    Doe B; Selby M; Barnett S; Baenziger J; Walker CM
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8578-83. PubMed ID: 8710913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of helper T cell-inducing peptides from conserved regions in HIV-1 env in a noncovalent mixture with a CTL-inducing V3-loop peptide for in vivo induction of long-lasting systemic CTL response.
    Nehete PN; Arlinghaus RB; Sastry KJ
    Viral Immunol; 1994; 7(4):189-97. PubMed ID: 7576033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid in vivo induction of HIV-specific CD8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of GP120.
    Sastry KJ; Nehete PN; Venkatnarayanan S; Morkowski J; Platsoucas CD; Arlinghaus RB
    Virology; 1992 Jun; 188(2):502-9. PubMed ID: 1316670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyriboinosinic polyribocytidylic acid [poly(I:C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8+ cytotoxic T lymphocytes.
    Fujimoto C; Nakagawa Y; Ohara K; Takahashi H
    Int Immunol; 2004 Jan; 16(1):55-63. PubMed ID: 14688061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.
    Lipford GB; Hoffman M; Wagner H; Heeg K
    J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM; Bonneau RH; Epler M; Tevethia MJ; Alam S; Verner K; Tevethia SS
    Virology; 1996 Aug; 222(1):269-74. PubMed ID: 8806508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens.
    Wijburg OL; van den Dobbelsteen GP; Vadolas J; Sanders A; Strugnell RA; van Rooijen N
    Eur J Immunol; 1998 Feb; 28(2):479-87. PubMed ID: 9521056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocytes against a soluble protein.
    Staerz UD; Karasuyama H; Garner AM
    Nature; 1987 Oct 1-7; 329(6138):449-51. PubMed ID: 2443853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The induction of cytotoxic T cells and tumor regression by soluble antigen formulation.
    Hariharan K; Braslawsky G; Black A; Raychaudhuri S; Hanna N
    Cancer Res; 1995 Aug; 55(16):3486-9. PubMed ID: 7627951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens.
    Bowen JC; Nair SK; Reddy R; Rouse BT
    Immunology; 1994 Mar; 81(3):338-42. PubMed ID: 8206507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.